Description
Each Late Breaking Clinical Trials and Science presenter will have 10 minutes to present their science. Each presentation will conclude with 3 minutes of commentary followed by 2 minutes of Chair-led Q&A.
Learning Objectives
- Assess the feasibility and outcomes of a large profile single shot pulse field technology for atrial fibrillation ablation.
- Compare the outcomes of left bundle branch area pacing to biventricular pacing in patients with mildly reduced ejection fraction for cardiac resynchronization.
- Describe the short-term results of a multi electrode novel large tipped point to point pulse field technology for atrial fibrillation ablation.
Session Chair(s)
Andrea Russo, MD
Dhanunjaya Lakkireddy, MBA, MD
Presentation
A Multielectrode Spherical Array Pulsed Field Ablation System to Treat Paroxysmal Atrial Fibrillation: 1-Year Outcomes of the PULSAR IDE Trial
Presenter(s): Vivek Y. Reddy, MD, Hans Kottkamp, MD, Hugh Calkins, MD, Devi G. Nair, MD, Philipp Sommer, MD, Ayman A. Hussein, MD, Burghard M. Schumacher, MD, Srinivas R. Dukkipati, MD, Petr Neuzil, MD, PhD, Saumil R. Oza, MD, Christopher Woods, MD, PhD, Marc W. Deyell, MD, MSci, Jose Osorio, MD, Atul Verma, MD
Commentary: A Multielectrode Spherical Array Pulsed Field Ablation System to Treat Paroxysmal Atrial Fibrillation: 1-Year Outcomes of the PULSAR IDE Trial
Presenter(s): Moussa Mansour, MD
Safety, Efficacy and PVI Durability of a Contact Force-Sensing Large-Tip Focal Pulsed Field Ablation Catheter Integrated With 3D Mapping to Treat Paroxysmal Atrial Fibrillation: First-in-Human Omny-IRE 3-Month Results
Presenter(s): Mattias Francis. Duytschaever, Massimo Grimaldi, MD, Tom De Potter, MD, PhD, Atul Verma, MD, Laurent Macle, MD, Josef Kautzner, MD, PhD, Dominik K. Linz, MD, PhD, Ante Anic, Hugo Van Herendael, Gediminas Rackauskas, MD, PhD, Petr Neuzil, MD, PhD, Julian Chun, Boris Schmidt, MD, Sebastien Knecht, MD, PhD, Alexandre Almorad, MD, Benjamin Berte, MD, MSci, PhD, Vivek Y. Reddy, MD, Johan M. Vijgen, MD
Commentary: Safety, Efficacy and PVI Durability of a Contact Force-Sensing Large-Tip Focal Pulsed Field Ablation Catheter Integrated With 3D Mapping to Treat Paroxysmal Atrial Fibrillation: First-in-Human Omny-IRE 3-Month Results
Presenter(s): T. Jared Bunch, MD
Left Bundle Branch Area Pacing Compared To Biventricular Pacing in Candidates for Cardiac Resynchronization Therapy (LVEF <50%) : Results From International Collaborative LBBAP Study (I-CLAS)
Presenter(s): Pugazhendhi Vijayaraman, MD, Ramez Morcos, MBA, MD, Óscar Cano, MD, PhD, Francesco Zanon, MD, Shunmuga Sundaram Ponnusamy, MBBS, MD, Bengt Herweg, MD, Parikshit S. Sharma, MD, MPH, Marek Jastrzebski, MD, PhD, Manuel Molina-Lerma, MD, Zachary I. Whinnett, BMBS, PhD, Kevin Vernooy, MD, PhD, Jiangang Zou, MD, PhD, Girish M. Nair, MBBS, MD, MHS, Rajeev Kumar. Pathak, MBBS, PhD, Roderick Tung, MD, Gaurav A. Upadhyay, MD, Karol Curila, Mihail G. Chelu, MD, PhD, Kenneth A. Ellenbogen, MD
Commentary: Left Bundle Branch Area Pacing Compared To Biventricular Pacing in Candidates for Cardiac Resynchronization Therapy (LVEF <50%) : Results From International Collaborative LBBAP Study (I-CLAS)
Presenter(s): Rajesh Kabra, MD
Atrial Fibrillation Recurrence After Left Atrial Appendage Occlusion in Patients Undergoing Atrial Fibrillation Ablation: Lessons from The OPTION Trial
Presenter(s): Arwa Younis, MD, Luigi Di Biase, MD, PhD, Roland R. Tilz, MD, Walid I. Saliba, MD, Mohamed Kanj, MD, Chadi Tabaja, MD, Christopher Woods, MD, PhD, Nicolas Lellouche, PASCAL DEFAYE, MD, Stephan Willems, MD, Thomas Christen, Kristine Roy, PhD, Brad Sutton, MBA, MD, Oussama M. Wazni, MD
Commentary: Atrial Fibrillation Recurrence After Left Atrial Appendage Occlusion in Patients Undergoing Atrial Fibrillation Ablation: Lessons from The OPTION Trial
Presenter(s): Larry A. Chinitz, MD
Disclosures
Vivek Reddy:
- Abbott (Honoraria/Speaking/Consulting Fee - Consulting)
- Acutus Medical Inc (Stock Options – Publicly Traded - Consulting)
- Affera, Inc. (Stocks – Privately Held - Consulting)
- Aquaheart (Stock Options – Privately Held (including start-up companies) - Consulting)
- Autonomix (Stock Options – Privately Held (including start-up companies) - Consulting)
- Axon (Stock Options – Privately Held (including start-up companies) - Consulting)
- BackBeat (Stock Options – Privately Held (including start-up companies) - Consulting)
- Biosig Technologies, Inc. (Stock Options – Publicly Traded - Consulting)
- Circa Scientific (Stock Options – Privately Held (including start-up companies) - Consulting)
- Corvia Medical (Stock Options – Privately Held (including start-up companies) - Consulting)
- EpiEP (Stocks – Privately Held - Consulting)
- CardioNXT (Stocks – Privately Held - Consulting)
- AFTX (Stock Options – Privately Held (including start-up companies) - Consulting)
- Farapulse (Stock Options – Privately Held (including start-up companies) - Consulting)
- FIRE1 (Stock Options – Privately Held (including start-up companies) - Consulting)
- Luxcath (Stock Options – Privately Held (including start-up companies) - Consulting)
- Manual Surgical Sciences (Stocks – Privately Held - Consulting)
- Medlumics (Stock Options – Privately Held (including start-up companies) - Consulting)
- NewPace Ltd (Stock Options – Privately Held (including start-up companies) - Consulting)
- Surecor (Stock Options – Privately Held (including start-up companies) - Consulting)
- VytronUS, Inc. (Stock Options – Privately Held (including start-up companies) - Consulting)
- Valcare (Stock Options – Privately Held (including start-up companies) - Consulting)
- CardiaCare (Stock Options – Privately Held (including start-up companies) - Consulting)
- Ablacon, Inc. (Stock Options – Privately Held (including start-up companies) - Consulting)
- Dinova (Stock Options – Privately Held (including start-up companies) - Consulting)
- Kardium (Stock Options – Privately Held (including start-up companies) - Consulting)
- HRT (Stock Options – Privately Held (including start-up companies) - Consulting)
- Intershunt (Stock Options – Privately Held (including start-up companies) - Consulting)
- AtaCor Medical Inc (Stock Options – Privately Held (including start-up companies) - Consulting)
- Sirona Medical Technologies, Inc (Stock Options – Privately Held (including start-up companies) - Consulting)
- CoreMap (Honoraria/Speaking/Consulting Fee - Consulting)
- Corisma Inc (Stock Options – Privately Held (including start-up companies) - Consulting)
- Restore Medical (Stocks – Privately Held - Consulting)
- VIZARAmed (Stocks – Privately Held - Consulting)
- Anumana (Stock Options – Privately Held (including start-up companies) - Consulting)
- APN Health (Stock Options – Privately Held (including start-up companies) - Consulting)
- EP Frontiers (Stock Options – Privately Held (including start-up companies) - Consulting)
- Field Medical (Stock Options – Privately Held (including start-up companies) - Consulting)
- Focused Therapeutics (Stock Options – Privately Held (including start-up companies) - Consulting)
- Javelin (Stock Options – Privately Held (including start-up companies) - Consulting)
- Oracle Health (Stock Options – Privately Held (including start-up companies) - Consulting)
- Soundcath (Stocks – Privately Held - Consulting)
- Abbott Medical (Honoraria/Speaking/Consulting Fee - Consulting)
- Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
- Atrian Medical Ltd. (Honoraria/Speaking/Consulting Fee - Consulting)
- BioTel (Honoraria/Speaking/Consulting Fee - Consulting)
- Biotronik (Honoraria/Speaking/Consulting Fee - Consulting)
- Boston Scientific (Honoraria/Speaking/Consulting Fee - Consulting)
- Cairdac (Honoraria/Speaking/Consulting Fee - Consulting)
- CardioFocus, Inc. (Stock Options – Privately Held (including start-up companies) - Consulting)
- W.L. Gore & Associates (Honoraria/Speaking/Consulting Fee - Consulting)
- Impulse Dynamics USA (Honoraria/Speaking/Consulting Fee - Consulting)
- Medtronic,Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
- Novo Nordisk (Honoraria/Speaking/Consulting Fee - Consulting)
- Novartis (Honoraria/Speaking/Consulting Fee - Consulting)
- Philips (Honoraria/Speaking/Consulting Fee - Consulting)
- Pulse Biosciences (Honoraria/Speaking/Consulting Fee - Consulting)
- Nyra Medical (Stocks – Privately Held - Consulting)
- DRS Vascular (Stocks – Privately Held - Consulting)
Moussa Mansour:
- Boston Scientific (Honoraria/Speaking/Consulting Fee - Consulting)
- KODEX -EPD (Stock Options – Privately Held (including start-up companies) - Consulting)
- NewPace Ltd (Stock Options – Privately Held (including start-up companies) - Consulting)
- Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
- Medtronic,Inc. (Honoraria/Speaking/Consulting Fee - Consulting)
- Siemens (Honoraria/Speaking/Consulting Fee - Consulting)
- Abbott (Honoraria/Speaking/Consulting Fee - Consulting)
Mattias Duytschaever:
- Nothing Relevant to Disclose
T. Jared Bunch:
- Boehringer Ingelheim (Research (Contracted Grants for PIs and Named Investigators only) - Research)
- Altathera (Research (Contracted Grants for PIs and Named Investigators only) - Research)
- Biosense Webster, Inc. (Training for new ablation balloon - Required training for new ablation balloon to start institutional research on the device)
- Pfizer, Inc. (Honoraria/Speaking/Consulting Fee - HRS committee for AF management - BMS/Pfizer Alliance and HRS Roundtable)
- Abbott (Research (Contracted Grants for PIs and Named Investigators only) - Research)
- Altathera (Research (Contracted Grants for PIs and Named Investigators only) - Creation of an education video based upon PEAKS registry data/study)
Pugazhendhi Vijayaraman:
- Biotronik (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
- Boston Scientific (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
- Medtronic (Research (Contracted Grants for PIs and Named Investigators only) - Research)
- Abbott Medical (Honoraria/Speaking/Consulting Fee - Consulting)
- Abbott (Honoraria/Speaking/Consulting Fee - Consulting)
- Medtronic (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
Rajesh Kabra:
- Nothing Relevant to Disclose
Arwa Younis:
- Nothing Relevant to Disclose
Larry Chinitz:
- Boston Scientific (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
- Abbott (Speakers' Bureau - Speaking and Teaching)
- Medtronic (Speakers' Bureau - Speaking and Teaching)
- Biotronik (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
- Biosense Webster, Inc. (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)
To view all Heart Rhythm 2025 Faculty Disclosures, please click
here.
Education Framework
Supraventricular Tachyarrhythmias
-- AFib and Flutter - Catheter Ablation
-- 143. Know the methods, techniques, associated tools, and equipment including emerging technologies to perform catheter ablation of atrial fibrillation and flutter.